LAUREN LINVILLE: Open Payments
NPI 1760890412 · MADISON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,444 in 80 payments from 18 companies in 2025. Trend: 2023 $1,017 · 2024 $1,292 · 2025 $1,444
Food & beverage: $1,444
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 27 | $467 |
| Novartis Pharmaceuticals Corporation | 15 | $271 |
| ABBVIE INC. | 13 | $225 |
| PFIZER INC. | 4 | $86 |
| Dexcom, Inc. | 4 | $80 |
| Astellas Pharma US Inc | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: LEQVIO, Ozempic, QULIPTA, Rybelsus, Dexcom G6 Transmitter, Veozah, UBRELVY, Wegovy.
Industry payments across WV — which companies pay providers there.
